Tag

Tau Protein

All articles tagged with #tau protein

Water Caps Identified as Key Mechanism in Tau Protein Misfolding for Alzheimer's
science3 hours ago

Water Caps Identified as Key Mechanism in Tau Protein Misfolding for Alzheimer's

Researchers at Northwestern University and UC Santa Barbara have identified a specific molecular mechanism by which tau proteins misfold into fibrils in Alzheimer's disease. Published in PNAS, the study reveals that water molecules form stabilizing caps around hydrophobic 'hotspots' on mutated tau proteins. When these caps release energy, they trigger the proteins to stack into rigid fibrils, which eventually kill brain cells and spread the disease. Blocking this hotspot with chemical tags halted fibril growth in tests, suggesting a potential target for future therapies.

Japanese Study Links Brain Waste Clearance to 40% Drop in Tau Protein
science9 days ago

Japanese Study Links Brain Waste Clearance to 40% Drop in Tau Protein

A Japanese research team reports that activating the brain's glymphatic waste-clearance system in mice reduced tau protein accumulation by 40%. While this suggests a potential path to slowing Alzheimer's progression, experts caution that human safety and efficacy remain unverified. Concurrent research highlights the complexity of brain waste removal, with new studies identifying additional lymphatic-like channels and emphasizing the critical role of sleep and cardiovascular health in maintaining this system.

Human Tau Strains Retain Structural Identity in Mouse Brains, Validating Prion-Like Transmission
science-and-health20 days ago

Human Tau Strains Retain Structural Identity in Mouse Brains, Validating Prion-Like Transmission

Researchers demonstrated that tau filaments from human Alzheimer’s and corticobasal degeneration brains can seed the formation of identical structures in mouse brains. This confirms that distinct tau folds act as prion-like strains, retaining their structural identity during transmission and driving disease-specific pathology.

Lymph Node Signals Drive Alzheimer’s Brain Damage, Study Finds
health-and-science23 days ago

Lymph Node Signals Drive Alzheimer’s Brain Damage, Study Finds

A new study from Washington University in St. Louis reveals that immune cells causing brain damage in Alzheimer’s disease are activated outside the brain, specifically in lymph nodes. By blocking these signals in mice, researchers prevented neurodegeneration and preserved cognitive abilities, even without removing toxic tau protein tangles. This suggests future treatments could target the immune system peripherally, bypassing the difficult blood-brain barrier.

Lymph Node Immune Signals, Not Tau Tangles, May Drive Alzheimer's Brain Damage
science26 days ago

Lymph Node Immune Signals, Not Tau Tangles, May Drive Alzheimer's Brain Damage

Researchers at Washington University in St. Louis have identified a peripheral immune mechanism that may explain why the body fails to heal Alzheimer's-related brain damage. Published in Nature Neuroscience, the study shows that dendritic cells in lymph nodes, not the brain itself, activate T cells that migrate to the brain and cause neurodegeneration. In mouse models, blocking these lymph node signals protected neurons and preserved cognition, even when toxic tau protein tangles remained in the brain. This suggests future treatments could target the immune system outside the blood-brain barrier, bypassing a major obstacle in drug delivery.

Alzheimer's research shifts focus from brain plaques to systemic immune and vascular triggers
health1 month ago

Alzheimer's research shifts focus from brain plaques to systemic immune and vascular triggers

Recent studies challenge the amyloid hypothesis, suggesting Alzheimer's may stem from vascular damage and peripheral immune activation rather than just protein buildup. Research shows dendritic cells in lymph nodes prime T cells that infiltrate the brain, driving tau-related damage, while vascular issues contribute to up to 45% of dementia cases. These findings highlight systemic origins and potential new therapeutic targets outside the brain.

Arc protein may ferry toxic Tau between neurons, unveiling a new Alzheimer’s therapeutic target
health-and-medicine3 months ago

Arc protein may ferry toxic Tau between neurons, unveiling a new Alzheimer’s therapeutic target

Mouse studies show Arc enables toxic Tau to spread between neurons via extracellular vesicles; removing Arc dramatically reduces Tau transfer, but Arc also helps neurons expel Tau, suggesting therapies should target the Tau-containing vesicles rather than Tau itself—offering a potential new route to slow Alzheimer's progression, though human relevance remains to be proven.

Cancer Drugs Reversing Alzheimer's Brain Changes in Mice Show Promise
science4 months ago

Cancer Drugs Reversing Alzheimer's Brain Changes in Mice Show Promise

US researchers used computational analysis to identify two FDA-approved cancer drugs, letrozole and irinotecan, that counteract Alzheimer’s-related gene-expression changes. In mouse models, when used together they reduced tau protein clumps and improved learning and memory, suggesting potential for repurposing and faster clinical testing, though safety in humans and side effects must be evaluated before any trials for Alzheimer's.

L-Arginine Stabilizes Protein Droplets to Halt Alzheimer’s Fibril Formation
science5 months ago

L-Arginine Stabilizes Protein Droplets to Halt Alzheimer’s Fibril Formation

UB scientists report that the cellular metabolite L-arginine stabilizes Tau-containing protein droplets, delaying their surface-initiated transition into toxic fibrils linked to Alzheimer’s while preserving the droplets’ ability to assemble microtubules; this demonstrates that droplet formation and fibril formation are separable and points to therapies that block fibril formation without disrupting condensate function (Nature Communications, 2026).

EPA-heavy fish oil may hinder brain repair after repeated head injuries
science5 months ago

EPA-heavy fish oil may hinder brain repair after repeated head injuries

A Cell Reports study in mice and human brain endothelial cells found that long-term fish oil supplementation high in EPA may reduce brain repair capacity and promote tau accumulation after repeated mild TBIs, while DHA showed no similar effect. The results suggest context-dependent effects of omega-3s on brain healing and are not yet proven in humans; individuals with a history of repeated head injuries should discuss fish oil use with a clinician.

Midlife Vitamin D Levels Tied to Lower Dementia Risk, Study Shows
wellness6 months ago

Midlife Vitamin D Levels Tied to Lower Dementia Risk, Study Shows

A Neurology study of 793 adults in their 30s–40s followed for 16 years found higher vitamin D in midlife associated with lower brain tau protein, a dementia-related marker, though amyloid levels weren’t affected and causality isn’t proven. With roughly 60% worldwide deficiency, researchers advise correcting vitamin D deficits and adopting brain-healthy habits—diet (fatty fish), regular physical activity, social and cognitive engagement, and managing vascular risks like diabetes, high blood pressure, and cholesterol—to support cognitive health later in life.

Sleep Clues in Early Alzheimer's: Tau, Glutamate, and Wakeful Nights
health7 months ago

Sleep Clues in Early Alzheimer's: Tau, Glutamate, and Wakeful Nights

A University of Kentucky study in mouse models links early Alzheimer’s sleep problems to tau-driven brain overactivity that shifts energy use to glutamate, causing insomnia and potentially preceding cognitive decline by years; the researchers say metabolic drugs used for epilepsy or type 2 diabetes could ease hyperactivity, improve sleep, and slow progression.

Tau hijacks brain energy, linking insomnia to early Alzheimer's
health7 months ago

Tau hijacks brain energy, linking insomnia to early Alzheimer's

A mouse study links early tau tangles to disrupted brain energy use, causing glutamate overproduction that keeps neurons awake and makes sleep hard, which may explain insomnia years before Alzheimer's; drugs that modulate brain metabolism—some used for epilepsy or type 2 diabetes—could improve sleep and potentially slow progression, though human confirmation is needed.

Parkinson's protein may accelerate Alzheimer's progression in women, study finds
health7 months ago

Parkinson's protein may accelerate Alzheimer's progression in women, study finds

A Mayo Clinic study of 415 participants found that older women with Alzheimer's who tested positive for the Parkinson's-related protein alpha-synuclein accumulated tau about 20 times faster than men with the same abnormal protein, suggesting alpha-synuclein may accelerate Alzheimer's progression in women. The findings indicate sex-specific disease trajectories and potential biomarker-guided therapies, but replication is needed before changing treatment approaches.

Blood tau clock could forecast when Alzheimer’s symptoms begin
health8 months ago

Blood tau clock could forecast when Alzheimer’s symptoms begin

A Nature Medicine study describes a blood test that detects an abnormal form of tau in the blood, which may serve as a molecular clock to predict not only if someone will develop Alzheimer’s but also when symptoms could start. If validated in larger trials, it could enable earlier interventions and streamline clinical testing for therapies, though experts caution that it’s not yet recommended for cognitively unimpaired individuals to use this biomarker outside of research.